Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach
Isidori, A.; Loscocco, F.; Ciciarello, M.; Corradi, G.; Lecciso, M.; Ocadlikova, D.; Parisi, S.; Salvestrini, V.; Amadori, S.; Visani, G.; Curti, A. Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach. Cancers 2018, 10, 211. https://0-doi-org.brum.beds.ac.uk/10.3390/cancers10070211
Isidori A, Loscocco F, Ciciarello M, Corradi G, Lecciso M, Ocadlikova D, Parisi S, Salvestrini V, Amadori S, Visani G, Curti A. Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach. Cancers. 2018; 10(7):211. https://0-doi-org.brum.beds.ac.uk/10.3390/cancers10070211
Chicago/Turabian StyleIsidori, Alessandro, Federica Loscocco, Marilena Ciciarello, Giulia Corradi, Mariangela Lecciso, Darina Ocadlikova, Sarah Parisi, Valentina Salvestrini, Sergio Amadori, Giuseppe Visani, and Antonio Curti. 2018. "Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach" Cancers 10, no. 7: 211. https://0-doi-org.brum.beds.ac.uk/10.3390/cancers10070211